Annual Operating Expenses
$383.30 M
+$104.70 M+37.58%
31 December 2023
Summary:
Immunocore Holdings annual total operating expenses is currently $383.30 million, with the most recent change of +$104.70 million (+37.58%) on 31 December 2023. During the last 3 years, it has risen by +$92.92 million (+32.00%). IMCR annual operating expenses is now at all-time high.IMCR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$88.30 M
-$1.41 M-1.57%
30 September 2024
Summary:
Immunocore Holdings quarterly total operating expenses is currently $88.30 million, with the most recent change of -$1.41 million (-1.57%) on 30 September 2024. Over the past year, it has increased by +$1.29 million (+1.48%). IMCR quarterly operating expenses is now -30.15% below its all-time high of $126.41 million, reached on 31 December 2022.IMCR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMCR Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +1.5% |
| 3 y3 years | +32.0% | +69.2% |
| 5 y5 years | +108.2% | +66.4% |
IMCR Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +37.6% | -30.1% | +126.2% |
| 5 y | 5 years | at high | +150.1% | -30.1% | +153.7% |
| alltime | all time | at high | +150.1% | -30.1% | +153.7% |
Immunocore Holdings Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $88.30 M(-1.6%) |
| June 2024 | - | $89.71 M(-7.3%) |
| Mar 2024 | - | $96.75 M(+11.2%) |
| Dec 2023 | $383.30 M(+37.6%) | $87.01 M(+10.5%) |
| Sept 2023 | - | $78.72 M(+7.6%) |
| June 2023 | - | $73.17 M(+5.8%) |
| Mar 2023 | - | $69.14 M(-45.3%) |
| Dec 2022 | $278.60 M | $126.41 M(+223.8%) |
| Sept 2022 | - | $39.04 M(-17.4%) |
| June 2022 | - | $47.26 M(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $50.82 M(-2.6%) |
| Dec 2021 | $290.38 M(+89.5%) | $52.18 M(-3.4%) |
| Sept 2021 | - | $53.99 M(+0.5%) |
| June 2021 | - | $53.70 M(-2.7%) |
| Mar 2021 | - | $55.19 M(+13.6%) |
| Dec 2020 | $153.25 M(-16.8%) | $48.59 M(+25.6%) |
| Sept 2020 | - | $38.68 M(+11.1%) |
| June 2020 | - | $34.81 M(-7.3%) |
| Mar 2020 | - | $37.57 M(-29.2%) |
| Dec 2019 | $184.09 M(+17.2%) | $53.08 M |
| Dec 2018 | $157.08 M | - |
FAQ
- What is Immunocore Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Immunocore Holdings?
- What is Immunocore Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Immunocore Holdings?
- What is Immunocore Holdings quarterly operating expenses year-on-year change?
What is Immunocore Holdings annual total operating expenses?
The current annual operating expenses of IMCR is $383.30 M
What is the all time high annual operating expenses for Immunocore Holdings?
Immunocore Holdings all-time high annual total operating expenses is $383.30 M
What is Immunocore Holdings quarterly total operating expenses?
The current quarterly operating expenses of IMCR is $88.30 M
What is the all time high quarterly operating expenses for Immunocore Holdings?
Immunocore Holdings all-time high quarterly total operating expenses is $126.41 M
What is Immunocore Holdings quarterly operating expenses year-on-year change?
Over the past year, IMCR quarterly total operating expenses has changed by +$1.29 M (+1.48%)